Hologic Showcases Advances across the Continuum of Breast Health at ECR 2022
July 13 2022 - 8:00AM
Business Wire
--Global Leader in Women's Health Highlights
Importance of Timely and Accurate Diagnosis--
Hologic, Inc. (Nasdaq: HOLX) will showcase their comprehensive
portfolio of breast and skeletal health solutions at the annual
European Congress of Radiology (ECR) in Vienna, Austria from July
13-17.
The pioneer behind 3D Mammography™ technology, Hologic will
provide attendees with an interactive experience that underscores a
commitment to innovation through advancements in breast screening,
surgery, biopsy and ultrasound solutions. As visitors explore the
clinically proven, integrated solutions across Hologic’s Breast
Health Continuum of Care, they can understand how these
technologies support the early detection and diagnostic needs of
patients.
“We’re thrilled to return to ECR to showcase how Hologic’s
product portfolio can support the needs of radiologists and
patients throughout the continuum of breast health,” said Tanja
Brycker, Vice President, Strategic Development, Breast and Skeletal
Health and Gynecological Surgical Solutions at Hologic. “Our
portfolio is designed to tackle today’s biggest challenges to early
detection‚ such as pandemic delays and radiology backlogs, in order
to help remove these barriers to diagnosis and treatment.”
Hologic’s ECR presence will also include the Scientific
Innovation Hub, where a wide variety of scientific talks led by
experts in the field will be hosted throughout the event. Medical
education sessions will focus on current topics, ranging from
personalization in breast cancer detection, contrast-enhanced
mammography in clinical practice, trends and practices in biopsy
and lesion localization, and ultrasound in clinical practice for
breast and liver. A full list of sessions will be available at the
Hub.
Additionally, the booth will feature findings from the Hologic
Global Women’s Health Index, developed in collaboration with the
Gallup World Poll. This multiyear, comprehensive global survey
provides an understanding of women’s perspectives and experiences
on key health topics. Throughout ECR, Hologic will share highlights
from the inaugural survey released in September 2021, so attendees
can learn about the state of women's health in their region.
For more information, or to register for a scientific session,
stop by Hologic’s booth in Foyer O on the first floor of the ACV
Main Congress building.
About Hologic, Inc.
Hologic, Inc. is an innovative medical technology company
primarily focused on improving women’s health and well-being
through early detection and treatment. For more information on
Hologic, visit www.hologic.com.
Hologic and 3D Mammography are trademarks and/or registered
trademarks of Hologic, Inc., and/or its subsidiaries in the United
States and/or other countries.
Forward-Looking Statements
This news release may contain forward-looking information that
involves risks and uncertainties, including statements about the
use of Hologic products. There can be no assurance these products
will achieve the benefits described herein or that such benefits
will be replicated in any particular manner with respect to an
individual patient, as the actual effect of the use of the products
can only be determined on a case-by-case basis. In addition, there
can be no assurance that these products will be commercially
successful or achieve any expected level of sales. Hologic
expressly disclaims any obligation or undertaking to release
publicly any updates or revisions to any such statements presented
herein to reflect any change in expectations or any change in
events, conditions or circumstances on which any such data or
statements are based.
SOURCE: Hologic, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220713005115/en/
Jane Mazur +1 508.263.8764 (direct) jane.mazur@hologic.com
Hologic (NASDAQ:HOLX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Hologic (NASDAQ:HOLX)
Historical Stock Chart
From Apr 2023 to Apr 2024